Many in vitro studies have examined the transport characteristics of the pars recta. Yet, because this nephron segment is inaccessible to direct micropuncture, its in vivo reabsorptive capacity remains unknown. In superficial nephrons, water movement between the late proximal and early distal tubule is limited to the pars recta and thin descending limb of Henle’s loop. Net water reabsorption in this latter segment is dependent on a favorable osmotic gradient generated by the hypertonic medullary interstitium. Accordingly, if this hypertonicity is abolished, net water movement between the late proximal and early distal tubule is limited to the pars recta. Since sodium reabsorption is isotonic along the pars recta, a comparison of fractional water delivery to the late proximal and early distal tubule provides an index of sodium reabsorption by this nephron segment. Therefore, furosemide was administered to 7 Munich-Wistar rats and micropuncture samples were obtained from the late proximal and early distal tubules. Ascending vasa recta (AVR) samples were also obtained and the ratio of AVR/plasma osmolality were determined and averaged 1.04, indicating that furosemide abolished medullary hypertonicity. The fractional delivery of filtrate to the late proximal tubule averaged 40.2% and that to the early distal tubule 30.0%, indicating that 10.2% of the filtered sodium was re-absorpbed along the pars recta. The administration of benzolamide, a carbonic anhydrase inhibitor, decreased this value to 5% of the filtered load.

Keywords:
Pars recta, Sodium reabsorption, Micropuncture
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.